Investigational Drug Information for Carmoterol
✉ Email this page to a colleague
What is the development status for investigational drug Carmoterol?
Carmoterol is an investigational drug.
There have been 5 clinical trials for Carmoterol.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2008.
The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive, and Lung Diseases. The leading clinical trial sponsors are Chiesi Farmaceutici S.p.A., Chiesi Pharmaceuticals Inc., and [disabled in preview].
Summary for Carmoterol
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,034 |
| WIPO Patent Applications | 642 |
| Japanese Patent Applications | 378 |
| Clinical Trial Progress | Phase 2 (2008-12-01) |
| Vendors | 24 |
Recent Clinical Trials for Carmoterol
| Title | Sponsor | Phase |
|---|---|---|
| Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma | Chiesi Farmaceutici S.p.A. | Phase 2 |
| Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD) | Chiesi Farmaceutici S.p.A. | Phase 2 |
| Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD) | Chiesi Pharmaceuticals Inc. | Phase 2 |
Clinical Trial Summary for Carmoterol
Top disease conditions for Carmoterol
Top clinical trial sponsors for Carmoterol
US Patents for Carmoterol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
